Does Molina Healthcare Stock Lead the Pack?
Molina Healthcare’s stock significantly underperformed most peers over the past year. A closer look reveals solid revenue growth and an attractive valuation, but profitability, especially free cash flow generation, lags behind top-performing rivals, limiting its appeal amidst potential sector consolidation.
- MOH’s 3.0% operating margin, modest yet above peers, lags UNH’s 6.1% due to UNH’s diversified, higher-margin Optum health services.
- MOH’s 13.7% revenue growth, outpacing UNH/CVS, reflects strong government program expansion and market share gains, though lagging CNC.
- MOH’s stock is down 37.9% amid sector regulatory/cost pressures. Its 10.9 PE suggests undervaluation but also investor skepticism on profit.
Here’s how Molina Healthcare stacks up across size, valuation, and profitability versus key peers.
| MOH | CNC | UNH | CVS | |
|---|---|---|---|---|
| Market Cap ($ Bil) | 9.6 | 21.9 | 309.9 | 102.1 |
| Revenue ($ Bil) | 44.5 | 185.9 | 435.2 | 394.1 |
| PE Ratio | 10.9 | -4.1 | 17.6 | 217.6 |
| LTM Revenue Growth | 13.7% | 14.9% | 10.5% | 6.8% |
| LTM Operating Margin | 3.0% | 0.6% | 6.1% | 2.7% |
| LTM FCF Margin | -1.3% | 1.8% | 4.0% | 1.6% |
| 12M Market Return | -37.9% | -27.3% | -31.7% | 83.2% |
For more details on Molina Healthcare, read Buy or Sell MOH Stock. Below we compare MOH’s growth, margin, and valuation with peers across years
Revenue Growth Comparison
- Rio Tinto’s Next Chapter: Growth, Guidance And Global Shifts
- Forget Timing the Bottom: Earn 10% While You Wait for BKNG on Sale
- What Could Send Micron Technology Stock Soaring
- Why U.S. Stocks Aren’t Crashing With Iran War
- Can Eli Lilly Stock Withstand These Pressures?
- Cash Rich, Low Price – Docusign Stock to Break Out?
| LTM | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| MOH | 13.7% | 19.3% | 6.6% | 15.1% |
| CNC | 14.9% | 5.9% | 6.5% | 14.7% |
| UNH | 10.5% | 7.7% | 14.6% | 12.7% |
| CVS | 6.8% | 4.2% | 10.9% | 10.4% |
Operating Margin Comparison
| LTM | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| MOH | 3.0% | 4.2% | 4.6% | 4.3% |
| CNC | 0.6% | 2.0% | 2.2% | 2.5% |
| UNH | 6.1% | 8.1% | 8.7% | 8.8% |
| CVS | 2.7% | 2.6% | 4.1% | 5.1% |
PE Ratio Comparison
| LTM | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| MOH | 10.9 | 8.4 | 15.4 | 26.4 |
| CNC | -4.1 | 6.5 | 12.2 | 35.5 |
| UNH | 17.6 | 21.1 | 21.0 | 24.5 |
| CVS | 217.6 | 21.7 | 6.9 | 24.0 |
Still not sure about MOH stock? Consider portfolio approach.
Portfolios Beat Stock Picking
Stocks soar and sink – the key is staying invested. A balanced portfolio keeps you in the market, boosts gains and reduces single stock risk
The Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming its benchmark that includes all 3 – the S&P 500, S&P mid-cap, and Russell 2000 indices. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.